Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin

BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) is an infectious disease common in immunocompromised hosts. However, the currently, the clinical characteristics of non-HIV patients with PJP infection have not been fully elucidated. AIM: To explore efficacy of trimethoprim–sulfamethoxazole (TMP-SM...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huan-Huan, Fang, Shuang-Yan, Chen, Yan-Xiao, Feng, Lan-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968794/
https://www.ncbi.nlm.nih.gov/pubmed/35434110
http://dx.doi.org/10.12998/wjcc.v10.i9.2743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968794/
https://www.ncbi.nlm.nih.gov/pubmed/35434110
http://dx.doi.org/10.12998/wjcc.v10.i9.2743

Ejemplares similares